- AVF Academy
- Sclerosant Selection Dosing
Sclerosant Selection Dosing
Sclerosant Selection Dosing
- Sep 14, 2026This Fellows Course discussion covered sclerotherapy agent choice, with most faculty preferring polidocanol for telangiectasi... more details
- Sep 14, 2026This Fellows Course industry talk reviewed Varithena, a 1 percent polidocanol injectable microfoam approved for incompetent g... more details
- Jul 16, 2026This issue focuses on aesthetic venous care, opening with a histology-based framework for matching sclerotherapy or laser tre... more details
- Mar 1, 2026Two talks on bringing an advanced practice provider into a vein practice and on the judgment behind good cosmetic sclerothera... more details
- Aug 5, 2025This industry-contributed issue profiles four venous care products. Methapharm describes its Asclera and ScleroSafe sclerothe... more details
- Feb 17, 2025A hands-on sclerotherapy workshop reviews the FDA-approved sclerosing agents polidocanol and sodium tetradecyl sulfate, their... more details
- Jul 25, 2024This Vein Specialist issue explores why physicians choose one sclerosing agent over another for treating telangiectasias and... more details
- Mar 3, 2024An entry-level sclerotherapy course for advanced practice providers covered the full workflow of treating spider and reticula... more details
- Mar 3, 2024This live demonstration session pairs real-time sclerotherapy injections on patients with running expert commentary on techni... more details
- Feb 24, 2023This Allied Health and Aesthetics program opened with a blueprint for onboarding advanced practice providers into a vein prac... more details
- Feb 26, 2022This aesthetic vein session opened with a case for building a cosmetic practice around trained staff and dedicated equipment,... more details

